[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-366328-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-366328-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","prognostic-and-immunological-significance-of-cd82-in-cancers-with-focus-on-hepatocellular-carcinoma-a-bioinformatics-approach","Prognostic and immunological significance of CD82 in cancers - with focus on hepatocellular carcinoma - A bioinformatics approach","","Despite significant successes, immunotherapy continues to face numerous challenges in practical applications. CD82 plays an important role in the tumor microenvironment (TME) across various cancers, yet its prognostic value in immunotherapy and its immune-response role remain unclear. Using human protein atlas for expression assessment, GSCA for associations with copy number variations (CNV) and methylation, TIMER for immune checkpoint and infiltration, and LinkedOmincs for enrichment, the study found CD82 mRNA downregulated across most tumor types. Abnormal CD82 expression tracked CNV and methylation changes and correlated with immune checkpoint gene activity, enhanced immune infiltration, and prognosis—especially in hepatocellular carcinoma—supporting CD82 as a prognostic biomarker and immunological target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/prognostic-and-immunological-significance-of-cd82-in-cancers-with-focus-on-hepatocellular-carcinoma-a-bioinformatics-approach/366328/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/prognostic-and-immunological-significance-of-cd82-in-cancers-with-focus-on-hepatocellular-carcinoma-a-bioinformatics-approach/366328.png","ImageObject",300,407,{"name":42,"@type":43},"Stanley","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What question does the study address about CD82?","Question",{"text":63,"@type":64},"It evaluates whether CD82 has prognostic value in immunotherapy and how CD82 relates to immune response within the tumor microenvironment.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which bioinformatics resources were used to analyze CD82?",{"text":68,"@type":64},"The study used Human Protein Atlas for expression, GSCA for CNV and methylation associations, TIMER for immune checkpoint and immune infiltration, and LinkedOmincs for enrichment analysis, with statistical testing performed in R.",{"name":70,"@type":61,"acceptedAnswer":71},"How is CD82 linked to prognosis and immune infiltration in cancers, especially liver cancer?",{"text":72,"@type":64},"Abnormal CD82 expression correlates with immune checkpoint gene activity, increased immune cell infiltration, and patient prognosis, with a notably strong effect in liver hepatocellular carcinoma.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},366328,1791037302,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336477405376,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","®  \n Observational Study   \nPrognostic and immunological significance of CD82 in cancers with focus on hepatocellular carcinoma  \nA bioinformatics approach  \nSikandar Ali, PhDa , Shiyu Liu, MSa , Jiali Chen, MSa , Jawad Ullah, MSa , Guoyu Mou, MBBSb , Xiaohua Huang, PhDa ,*  \n\n| Abstract\u003Cbr>Despite significant successes, immunotherapy continues to face numerous challenges in practical applications. CD82 plays an important role in the tumor microenvironment (TME) across various cancers. However, the prognostic value of CD82 in immunotherapy and its role in the immune response remain unclear. The expression levels of CD82 in healthy human tissues were assessed using the human protein atlas (HPA) database tool. The association among CD82 expression levels, copy number variations (CNV), and methylation was explored using the gene set cancer analysis (GSCA) database. Timer tumor immune estimation resource (TIMER) database is used for immune checkpoint and immune infiltration. The LinkedOmincs database is used for enrichment analysis. The statistical inquiry was performed through the R program (version 4.4. 1) . The result has shown that CD82 mRNA levels were significantly downregulated in most tumor types. Abnormal CD82 mRNA expression was associated with CNV and methylation changes in tumor tissues. Furthermore, several immune checkpoint genes related to CD82 influenced prognosis and were linked to increased immune cell infiltration across various cancer forms, including liver hepatocellular carcinoma (LIHC) . The prognosis of the patients under multiple cancer forms, particularly LIHC, was remarkably influenced by CD82, which plays a vital role in modulating immune infiltration. CD82 has the potential to serve as both a prognostic indicator and an immunological biomarker in human cancer. CD82 expression is frequently downregulated across various cancer associated with poor prognosis, influenced by CNV and DNA methylation alterations. Its abnormal expression correlates with changes in immune checkpoint gene activity and enhanced immune cell infiltration, notably in liver. These associations suggest that CD82 plays a significant role in shaping the tumor immune microenvironment and affects patient prognosis. Consequently, CD82 holds promise as both a prognostic biomarker and an immunomodulatory target in cancer immunotherapy. |\n| --- |\n| Abbreviations: ACC = adrenocortical carcinoma, AML = acute myeloid leukemia, BLCA = bladder urothelial carcinoma, BRCA = breast invasive carcinoma, CESC = cervical squamous cell carcinoma and endocervical adenocarcinoma, CHOL = cholangiocarcinoma, COAD = colon adenocarcinoma, DLBC = diffuse large B-cell lymphoma, ESCA = esophageal carcinoma, GBM = glioblastoma multiforme, GBMLGG = glioblastoma and lower grade glioma, HCC = hepatocellular carcinoma, HNSC = head and neck squamous cell carcinoma, KICH = kidney chromophobe, KIPAN = pan-kidney cancer group, KIRC = kidney renal clear cell carcinoma, KIRP = kidney renal papillary cell carcinoma, LGG = brain lower grade glioma, LIHC = liver hepatocellular carcinoma, LUAD = lung adenocarcinoma, LUSC = lung squamous cell carcinoma, MESO = mesothelioma, OV = ovarian serous cystadenocarcinoma, PAAD = pancreatic adenocarcinoma, PRAAD = prostate adenocarcinoma, READ = rectum adenocarcinoma, SARC = sarcoma, SKCM = skin cutaneous melanoma, STAD = stomach adenocarcinoma, TGCT = testicular germ cell tumor, THCA = thyroid carcinoma, THYM = thymoma, UCS = uterine carcinoma, UVM = uveal melanoma. |\n| Keywords: bioinformatic, CD82 , hepatocellular carcinoma prognosis, immune checkpoints, pan-cancer, tumor microenvironment |\n\nThis work was supported by the Liaoning Provincial Department of Education Basic Research Project (LJKZ0831).  \nThe authors have no conflicts of interest to disclose.  \nAll data generated or analyzed during this study are included in this published article [and its supplementary information files].  \nThis study used data obtained exclusively from pu","cbCaig1KXUQG2UGs","https://ap.wps.com/l/cbCaig1KXUQG2UGs","pdf",3281692,11,"English","# 1. Introduction","[{\"question\":\"What question does the study address about CD82?\",\"answer\":\"It evaluates whether CD82 has prognostic value in immunotherapy and how CD82 relates to immune response within the tumor microenvironment.\"},{\"question\":\"Which bioinformatics resources were used to analyze CD82?\",\"answer\":\"The study used Human Protein Atlas for expression, GSCA for CNV and methylation associations, TIMER for immune checkpoint and immune infiltration, and LinkedOmincs for enrichment analysis, with statistical testing performed in R.\"},{\"question\":\"How is CD82 linked to prognosis and immune infiltration in cancers, especially liver cancer?\",\"answer\":\"Abnormal CD82 expression correlates with immune checkpoint gene activity, increased immune cell infiltration, and patient prognosis, with a notably strong effect in liver hepatocellular carcinoma.\"}]","Prognostic and immunological significance of CD82 in cancers - with focus on hepatocellular carcinoma - A bioinformatics approach | PDF",1790164833,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1b9a35de847b66e17a4eff32d70463c3.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/257f37115ca564b247ae5a78af687df9.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/086582d94271022079d0b3bda86532ad.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d84a1918ba9f36dd293cf0ef71fe0fe.webp",980,1306]